There are roughly 2.5 million people living with diabetes in Ukraine, many of whom are Type 1 diabetics that need multiple daily injections of insulin to survive. However, for those living in high-conflict areas of the country, access to life-saving insulin is limited or non-existent. Because insulin is a temperature-sensitive product, quick and safe transportation of the insulin is a top priority, making delivering the drug to areas of conflict a struggle.
In response to this immediate need, Kin Communications, NuGen M.D., Draganfly Inc., and Coldchain Technology Services are working together with Revived Soldiers Ukraine (RSU) to deliver NuGen’s needle-free injection systems and insulin to areas affected by the conflict in Ukraine via Draganfly's Medical Response drones.
Revived Soldiers Ukraine (RSU), a non-profit organization dedicated to providing aid to the people of Ukraine, will use Draganfly's Medical Response Drones to deliver NuGen’s needle-free InsuJetTM injection device, filled with 10 milliliters of insulin to those high-conflict areas of Ukraine in dire and urgent need.
Insulin has been sourced at a significantly reduced price through Coldchain Technology Services, LLC, to help those in need in Ukraine get access to insulin injections.
Kin's immediate goal is to raise $250,000 to fund the initial purchase of this necessary insulin, but we ask that you join us as we tirelessly aim to raise $5 million. But why stop there. There is an immediate and ongoing need as this country is ravaged by these senseless acts of violence.
Every needless death in this war is a crime against humanity.
Together, we can support Ukraine diabetics in IMMEDIATE NEED and make a very meaningful difference.
Donate NOW, and provide life-saving support to the millions living with diabetes in Ukraine.
~$520 CDN provides enough insulin for 1 diabetic in need for 1 Month (yes, it IS that expensive )
~$17.50 CDN provides enough insulin for 1 diabetic in need for a day
Help Ukraine Diabetics in Need and DONATE TODAY!
About the Coalition:
Revived Soldiers Ukraine
Revived Soldiers Ukraine (RSU) is a non-profit organization dedicated to providing aid to the people of Ukraine so that they may fulfill fundamental rights and freedoms such as right to life, right to appropriate and affordable medical care, freedom of belief and freedom for an adequate standard of living. Learn more: www.rsuukraine.org
Kin Communications is a full-service investor relations agency with over 15 years of experience across multiple industries including technology, mining, and life science. Our goal is to foster long-term relationships that begin by picking up the phone and starting a conversation. The founder, President and CEO, Arlen Hansen, (and family members) are diabetics and are privileged to live in a country supported a medical system that subsidizes their medications and have taken this initiative to assist those suffering from diabetes in Ukraine. Learn more: www.kincommunications.com
NuGen Medical Devices is a medical device company developing the next generation of needle-free technology to improve the lives of millions of diabetics requiring daily insulin injections to stay alive. To learn more: www.nugenmd.com
Draganfly Inc. is the creator of quality, cutting-edge drone solutions, software, and AI systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 20 years, Draganfly is an award-winning industry leader serving the public safety, public health, mining, agriculture, industrial inspections, security, mapping, and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives. To learn more: www.draganfly.com
Coldchain Technology Services , located in Spring Branch, Texas, was founded in 2006 and is a Service-Disabled Veteran Owned Small Business focused on providing cold chain management solutions for the storage and distribution of time temperature sensitive products. CTS operations meet or exceed current Good Manufacturing Practices (cGMP) regulatory compliance standards as outlined by the FDA and are VAAWD accredited for drug distribution and supply chain design. Their clients include, Centers for Disease Control and Prevention, Department of Public Health Chicago, U.S Food and Drug Administration, Depart of Health & Human Services, World Health Organization, National Institute of Health, Johnson & Johnson, amongst others. Learn more: www.coldchain-tech.com
All funds raised, will towards the purchase of insulin to be administered and delivered with NuGen M.D’s needle-free injection device also known as InsuJet™. NuGen M.D is a client of KIN Communications Inc., I have no business ties, or family ties to the diabetics that will receive this aid from the coalition. I am a diabetic, I have family members who are diabetic, I have friends who are Ukrainian. None of the funds received from the campaign will go to friends, relatives, friends, families who are diabetic. All parties mentioned above are either donating their time, services, medical devices, or margins. A minimum of $70,000 CDN is required to begin the delivery of insulin along with NuGen M.D's needle free injection system. If this is not met, funds will directed to a Canadian based Ukraine Charitable Society. A client of KIN Communications, NuGen M.D is donating the need free systems and accessories for the purpose of this initiative, I have no other business affiliations with companies mentioned above.
If you have any questions or concerns, please call me directly at [phone redacted] or email me at [email redacted]
All funds raised, will go towards purchase and delivery insulin from the suppliers. I have no business ties, or family ties to the diabetics that will receive this aid from the coalition. I am a diabetic, I have family members who are diabetic, I have friends who are Ukrainian. None of the funds received from the campaign will go to friends, relatives, friends, families who are diabetic. All parties mentioned above are either donating their time, services, medical devices, or margins. A minimum of $70,000 CDN is required to begin the delivery of insulin along with NuGen M.D's needle free injection system. If this is not met, funds will directed to a Ukraine Charitable Society. A client of KIN Communications, NuGen M.D is donating the need free systems and accessories for the purpose of this initiative, I have no other business affiliations with companies mentioned above.
Please read this disclaimer in its entirety before making any donations, reviewing any opinions, views or information expressed by Kin Communications Inc. (“Kin”). If you do not agree to all of the disclaimer, do not access any materials or information presented by Kin. By accessing these materials, and whether or not you have actually read this disclaimer, you are deemed to have accepted it.
The opinions or views expressed on all channels, including social media platforms, email newsletters, and websites maintained by Kin Communications Inc. (“Kin”) represent the thoughts and opinions of individual users. The opinions and views expressed on these channels do not in any way reflect the views of the site they are posted on, other sites affiliated with those sites, or the Kin staff involved with maintaining the site. Kin does not control or guarantee the accuracy, relevance, timelines or completeness of opinions, views and information presented on these channels. While Kin makes reasonable efforts to verify the accuracy of information presented, readers are strongly encouraged to conduct their own independent due diligence.
No opinions, views or information presented should be construed as a solicitation to buy or sell the securities of any third-party mentioned. Kin, and its principals, are not registered broker-dealers or financial advisors. Before making an investment in any securities, you should consult with your financial advisor and a registered broker-dealer. Never make investment decisions based solely on opinions, views or information presented on these sites. In certain cases, Kin is paid by third-parties mentioned on these sites to disclose information and opinions. In addition, Kin and its principals may own securities of those parties mentioned. As a result, Kin and its principals would have a direct financial interest in the parties mentioned. Therefore, any information provided should not be construed as independent financial analysis or recommendations but as advertisement.
Certain information presented may contain or be considered forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors which may cause actual results or events to differ materially from those anticipated in these statements. There can be no assurance that any such statements will prove to be accurate, and readers should not place undue reliance on such information. Kin does not undertake any obligations to update information presented, or to ensure that such information remains current and accurate.